4.6 Article

Mapping of the CD23 Binding Site on Immunoglobulin E (IgE) and Allosteric Control of the IgE-FcεRI Interaction

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 37, Pages 31457-31461

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.C112.397059

Keywords

-

Funding

  1. Wellcome Trust
  2. Medical Research Council
  3. MRC [G0001352, G0400106] Funding Source: UKRI
  4. Medical Research Council [G0400106, G1000758, MR/J006742/1, G1000758B, G0001352] Funding Source: researchfish
  5. National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish

Ask authors/readers for more resources

IgE, the antibody that mediates allergic responses, acts as part of a self-regulating protein network. Its unique effector functions are controlled through interactions of its Fc region with two cellular receptors, Fc epsilon RI on mast cells and basophils and CD23 on B cells. IgE cross-linked by allergen triggers mast cell activation via Fc epsilon RI, whereas IgE-CD23 interactions control IgE expression levels. We have determined the CD23 binding site on IgE, using a combination of NMR chemical shift mapping and site-directed mutagenesis. We show that the CD23 and Fc epsilon RI interaction sites are at opposite ends of the C epsilon 3 domain of IgE, but that receptor binding is mutually inhibitory, mediated by an allosteric mechanism. This prevents CD23-mediated cross-linking of IgE bound to Fc epsilon RI on mast cells and resulting antigen-independent anaphylaxis. The mutually inhibitory nature of receptor binding provides a degree of autonomy for the individual activities mediated by IgE-Fc epsilon RI and IgE-CD23 interactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available